基于机器学习的高血压发病影响因素的巢式病例对照研究
A Nested Case-Control Study on Machine Learning-Based Risk Factors for Hypertension
DOI: 10.12677/acm.2025.15113179, PDF,   
作者: 刘慧敏:甘肃中医药大学第一临床医学院,甘肃 兰州;梁小霞, 高 敏, 李 一:甘肃中医药大学第一临床医学院,甘肃 兰州;甘肃省人民医院全科医学科,甘肃 兰州;王效浣*:甘肃中医药大学第一临床医学院,甘肃 兰州;甘肃省人民医院心内四科,甘肃 兰州
关键词: 高血压相关风险因素巢式病例对照研究Hypertension Influencing Factors Nested Case-Control Study
摘要: 目的:研究高血压发病的影响因素,并为高血压的防治提供科学依据。方法:基于中国健康与养老追踪调查(China Health and Retirement Longitudinal Study, CHARLS)数据库,以2011~2018年中4次随访中新发的1946例高血压患者为新发病例组,按照年龄(±2岁)和性别1:1个体匹配的方法,选取同期未发生高血压患者为对照组,最终纳入研究对象3668例。采用条件Logistic回归模型、限制性立方样条模型及梯度提升机模型(Gradient Boosting Machine Mode, GBM)探讨高血压发病的相关风险因素。结果:多因素条件Logistic回归模型显示甘油三脂(Triglycerides, TG)、C-反应蛋白(C-reactive protein, CRP)、高密度脂蛋白胆固醇(High-Density Lipoprotein Cholesterol, HDL-C)及腰围与高血压存在关联,其OR值分别是1.01 (95% CI: 1.00~1.02)、1.01 (95% CI: 1.00~1.03)、1.0 (95% CI: 1.00~1.01)、1.03 (5% CI: 1.02~1.03)。限制性立方样条模型结果显示,尿酸(Uric Acid, UA)水平与高血压发病之间存在正向非线性剂量–反应关系(UA:P总趋势 = 0.012,P非线 = 0.026),GBM模型中根据SHAP (SHapley Additive exPlanations)值显示,胱抑素C对高血压的发病具有较大的正向影响。结论:本研究发现腰围、TG、HDL-C、UA、胱抑素C、CRP是高血压发病的相关风险因素,同时发现UA水平与高血压发病之间存在正向非线性剂量–反应关系。
Abstract: Objective: To study the influencing factors on the development of hypertension and provide a scientific basis for the prevention and treatment of hypertension. Methods: Based on the China Health and Retirement Longitudinal Study (CHARLS) database, 1946 patients with new-onset hypertension during the 4 follow-ups between 2011 and 2018 as the case group, and selecting a control group of subjects who did not develop hypertension during the same period using a 1:1 individual matching method based on age (±2 years) and gender, a total of 3668 subjects were included in the study. Conditional logistic regression models, restricted cubic spline models, and gradient boosting machines (GBM) models were employed to explore the influencing factors of hypertension onset. Results: The multifactorial conditional logistic regression model showed that triglyceride (TG), C-reactive protein (CRP), high-density lipoprotein cholesterol (HDL-C), and waist circumference were associated with hypertension, with OR values of 1.01 (95% CI: 1.00~1.02), 1.01 (95% CI: 1.00~1.03), and 1.01 (95% CI: 1.00~1.01), 1.03 (95% CI: 1.02~1.03). Restricted cubic spline modeling results showed a positive nonlinear dose-response relationship between uric acid (UA) levels and the development of hypertension (UA: P total trend = 0.012, P nonlinear = 0.026), and in GBM modeling based on SHAP values showed a large positive effect of cystatin C on the development of hypertension. Conclusion: This study found that waist circumference, TG, HDL-C, UA, cystatin C, and CRP are influencing factors for the onset of hypertension. Additionally, a positive non-linear dose-response relationship was observed between UA levels and the risk of hypertension development.
文章引用:刘慧敏, 梁小霞, 高敏, 李一, 王效浣. 基于机器学习的高血压发病影响因素的巢式病例对照研究[J]. 临床医学进展, 2025, 15(11): 954-963. https://doi.org/10.12677/acm.2025.15113179

参考文献

[1] 何金玉, 朱丽都孜·解思思别克, 张宁, 等. 我国规范化管理高血压患者血压控制及影响因素研究的现状、挑战与未来展望[J/OL]. 中国全科医学, 2025.
https://link.cnki.net/urlid/13.1222.R.20250507.1704.002, 2025-05-08.
[2] 吴春香, 田婕, 郭毅, 等. 高血压患者8年就医行为轨迹及影响因素分析[J/OL]. 中国全科医学, 2025.
https://link.cnki.net/urlid/13.1222.R.20250507.1756.004, 2025-05-08.
[3] 黄文博, 冯娴, 姚元龙, 等. 全科医学视角下我国高血压患者的自我管理[J]. 中华全科医学2022, 20(7): 1085-1088.
[4] 中国高血压防治指南修订委员会. 中国高血压防治指南(2024年修订版) [J]. 中华高血压杂志(中英文), 2024, 32(7): 603-700.
[5] Yan, J., Zhang, M. and He, Q. (2024) Association of Changes and Cumulative Measures of Triglyceride-Glucose Index-Body Mass Index with Hypertension Risk: A Prospective Cohort Study. BMC Public Health, 24, Article No. 2652. [Google Scholar] [CrossRef] [PubMed]
[6] Yang, Y., Sun, Q., Ma, S., Li, X., Lang, X. and Zhang, Q. (2024) Association of Serum Creatinine to Cystatin C to Waist Circumference Ratios and Hypertension: Evidence from China Health and Retirement Longitudinal Study. Frontiers in Endocrinology, 15, Article ID: 1387374. [Google Scholar] [CrossRef] [PubMed]
[7] Nikbakht, H.R., Najafi, F., Shakiba, E., Darbandi, M., Navabi, J. and Pasdar, Y. (2023) Triglyceride Glucose-Body Mass Index and Hypertension Risk in Iranian Adults: A Population-Based Study. BMC Endocrine Disorders, 23, Article No. 156. [Google Scholar] [CrossRef] [PubMed]
[8] Jia, G., Sowers, J.R. and Whaley-Connell, A.T. (2024) Obesity in Hypertension: The Role of the Expanding Waistline over the Years and Insights into the Future. Hypertension, 81, 687-690. [Google Scholar] [CrossRef] [PubMed]
[9] Nimptsch, K., Konigorski, S. and Pischon, T. (2019) Diagnosis of Obesity and Use of Obesity Biomarkers in Science and Clinical Medicine. Metabolism, 92, 61-70. [Google Scholar] [CrossRef] [PubMed]
[10] 冯小燕, 王军义, 吴珊, 等. 中山市体检老年人腹部肥胖指标与高血压患病关系[J]. 中国公共卫生, 2023, 39(11): 1397-1406.
[11] Xu, Y., Shi, Z., Sun, D., Munivrana, G., Liang, M., István, B., et al. (2023) Establishment of Hypertension Risk Nomograms Based on Physical Fitness Parameters for Men and Women: A Cross-Sectional Study. Frontiers in Cardiovascular Medicine, 10, Article ID: 1152240. [Google Scholar] [CrossRef] [PubMed]
[12] Sun, J., Ma, Y., Liu, H., Qu, Q., Cheng, C., Kong, X., et al. (2022) High Waist Circumference Is a Risk Factor of New‐onset Hypertension: Evidence from the China Health and Retirement Longitudinal Study. The Journal of Clinical Hypertension, 24, 320-328. [Google Scholar] [CrossRef] [PubMed]
[13] 张景锋, 李文宇, 陈敏琪, 等. 潮州市居民肥胖状态与高血压关联强度的剂量-反应关系[J]. 中华疾病控制杂志, 2022, 26(2): 144-149.
[14] Mfuru, G.H., Allan, J.N., Njau, A., Ubuguyu, O. and Malima, K.Y. (2024) Using Waist Circumference as a Predictor of Hypertension in Manzese, Dar Es Salaam: A Community-Based Cross-Sectional Study, 2023. BMC Public Health, 24, Article No. 3618. [Google Scholar] [CrossRef] [PubMed]
[15] 周传飞, 符秀英, 周兴业, 等. 肥胖致高血压机制的研究进展[J]. 赣南医学院学报, 2022, 42(12): 1268-1278.
[16] Kansui, Y., Matsumura, K., Morinaga, Y., Inoue, M., Kiyohara, K., Ohta, Y., et al. (2019) C-Reactive Protein and Incident Hypertension in a Worksite Population of Japanese Men. The Journal of Clinical Hypertension, 21, 524-532. [Google Scholar] [CrossRef] [PubMed]
[17] Su, Y., Sun, J., Su, Z. and Sun, W. (2024) Revisiting Waist Circumference: A Hypertension Risk Factor That Requires a More In-Depth Understanding. Current Cardiology Reviews, 20, 77-85. [Google Scholar] [CrossRef] [PubMed]
[18] de Kreutzenberg, S.V., Puato, M., Kiwanuka, E., Del Prato, S., Pauletto, P., Pasini, L., et al. (2003) Elevated Non-Esterified Fatty Acids Impair Nitric Oxide Independent Vasodilation, in Humans: Evidence for a Role of Inwardly Rectifying Potassium Channels. Atherosclerosis, 169, 147-153. [Google Scholar] [CrossRef] [PubMed]
[19] Celermajer, D.S., Sorensen, K.E., Gooch, V.M., Spiegelhalter, D.J., Miller, O.I., Sullivan, I.D., et al. (1992) Non-Invasive Detection of Endothelial Dysfunction in Children and Adults at Risk of Atherosclerosis. The Lancet, 340, 1111-1115. [Google Scholar] [CrossRef] [PubMed]
[20] Kajikawa, M., Maruhashi, T., Matsumoto, T., Iwamoto, Y., Iwamoto, A., Oda, N., et al. (2016) Relationship between Serum Triglyceride Levels and Endothelial Function in a Large Community-Based Study. Atherosclerosis, 249, 70-75. [Google Scholar] [CrossRef] [PubMed]
[21] Laaksonen, D.E., Niskanen, L., Nyyssonen, K., Lakka, T.A., Laukkanen, J.A. and Salonen, J.T. (2008) Dyslipidaemia as a Predictor of Hypertension in Middle-Aged Men. European Heart Journal, 29, 2561-2568. [Google Scholar] [CrossRef] [PubMed]
[22] Tomita, Y., Sakata, S., Arima, H., Yamato, I., Ibaraki, A., Ohtsubo, T., et al. (2021) Relationship between Casual Serum Triglyceride Levels and the Development of Hypertension in Japanese. Journal of Hypertension, 39, 677-682. [Google Scholar] [CrossRef] [PubMed]
[23] Zhang, Y., Li, S., Xu, R., Guo, Y., Wu, N., Zhu, C., et al. (2015) Distribution of High-Density Lipoprotein Subfractions and Hypertensive Status. Medicine, 94, e1912. [Google Scholar] [CrossRef] [PubMed]
[24] Chen, S. and Cheng, W. (2022) Relationship between Lipid Profiles and Hypertension: A Cross-Sectional Study of 62,957 Chinese Adult Males. Frontiers in Public Health, 10, Article ID: 895499. [Google Scholar] [CrossRef] [PubMed]
[25] Trimarco, V., Izzo, R., Morisco, C., Mone, P., Virginia Manzi, M., Falco, A., et al. (2022) High HDL (High-Density Lipoprotein) Cholesterol Increases Cardiovascular Risk in Hypertensive Patients. Hypertension, 79, 2355-2363. [Google Scholar] [CrossRef] [PubMed]
[26] 孙丽荣, 叶润宇, 张鑫, 等. 高尿酸损害高血压患者的内皮功能[J]. 中华高血压杂志(中英文), 2025, 33(1): 82-87.
[27] Zheng, R., Yang, T., Chen, Q., Chen, C. and Mao, Y. (2017) Serum Uric Acid Concentrations Can Predict Hypertension: A Longitudinal Population-Based Epidemiological Study. Hormone and Metabolic Research, 49, 873-879. [Google Scholar] [CrossRef] [PubMed]
[28] Poudel, B., Yadav, B.K., Kumar, A., Jha, B. and Raut, K.B. (2014) Serum Uric Acid Level in Newly Diagnosed Essential Hypertension in a Nepalese Population: A Hospital Based Cross Sectional Study. Asian Pacific Journal of Tropical Biomedicine, 4, 59-64. [Google Scholar] [CrossRef] [PubMed]
[29] Sanchez-Lozada, L.G., Rodriguez-Iturbe, B., Kelley, E.E., Nakagawa, T., Madero, M., Feig, D.I., et al. (2020) Uric Acid and Hypertension: An Update with Recommendations. American Journal of Hypertension, 33, 583-594. [Google Scholar] [CrossRef] [PubMed]
[30] Ofori, S. and Odia, O. (2014) Serum Uric Acid and Target Organ Damage in Essential Hypertension. Vascular Health and Risk Management, 10, 253-261. [Google Scholar] [CrossRef] [PubMed]
[31] Kestenbaum, B., Rudser, K.D., de Boer, I.H., Peralta, C.A., Fried, L.F., Shlipak, M.G., et al. (2008) Differences in Kidney Function and Incident Hypertension: The Multi-Ethnic Study of Atherosclerosis. Annals of Internal Medicine, 148, 501-508. [Google Scholar] [CrossRef] [PubMed]
[32] Li, J., Fang, C. and Hui, R. (2005) Is Hypertension an Inflammatory Disease? Medical Hypotheses, 64, 236-240. [Google Scholar] [CrossRef] [PubMed]
[33] Sproston, N.R. and Ashworth, J.J. (2018) Role of C-Reactive Protein at Sites of Inflammation and Infection. Frontiers in Immunology, 9, Article ID: 754. [Google Scholar] [CrossRef] [PubMed]
[34] Sung, K., Ryu, S., Sung, J., Kim, Y.B., Won, Y.S., Cho, D.S., et al. (2017) Inflammation in the Prediction of Type 2 Diabetes and Hypertension in Healthy Adults. Archives of Medical Research, 48, 535-545. [Google Scholar] [CrossRef] [PubMed]
[35] He, L., Fan, C. and Li, G. (2022) The Relationship between Serum C-Reactive Protein and Senile Hypertension. BMC Cardiovascular Disorders, 22, Article No. 500. [Google Scholar] [CrossRef] [PubMed]
[36] Hage, F.G. (2013) C-Reactive Protein and Hypertension. Journal of Human Hypertension, 28, 410-415. [Google Scholar] [CrossRef] [PubMed]
[37] 张玉飞, 格桑平措, 胡一琳, 等. 西藏地区藏族人群高血压与同型半胱氨酸水平及亚甲基四氢叶酸还原酶和甲硫氨酸合成酶还原酶基因多态性的关联[J]. 现代医药卫生, 2024, 40(24): 4167-4172.
[38] 孙慧敏, 王嘉伟, 孙品一, 等. 基于Logistic回归模型分析的高血压影响因素研究[J]. 现代医药卫生, 2024, 40(24): 4167-4172.